Author: Katschnig H. Berger P.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 207-207
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Impaired QOL with social phobia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. :
Basic and clinical aspects of social phobia
By den Boer J.A. van Vliet I.M. Westenberg H.G.M.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Interaction of drugs and psychotherapy in social phobia
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Prevalence, lifecourse and disability in social phobia
By Judd L.L.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
WPA educational programme on social phobia
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :